98 related articles for article (PubMed ID: 25528832)
21. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurova FKh
Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
[TBL] [Abstract][Full Text] [Related]
22. Clinical effect of the extract of TCM Fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease.
Hongguang J; Xingjie H; Mingliang J; Yun L; Tongjian L; Jingmo Y; Liang L; Lifang Z
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):433-437. PubMed ID: 30852481
[TBL] [Abstract][Full Text] [Related]
23. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
Jain P
J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
[No Abstract] [Full Text] [Related]
24. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
25. Management of intrahepatic cholestasis of pregnancy.
Marschall HU
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1273-9. PubMed ID: 26313609
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Marschall HU
Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
[No Abstract] [Full Text] [Related]
27. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
28. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
29. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
30. Intrahepatic cholestasis and eclampsia: a case report.
Atabey S; Duvan CI; Eren U; Turhan NO
Hypertens Pregnancy; 2007; 26(4):363-9. PubMed ID: 18066956
[TBL] [Abstract][Full Text] [Related]
31. [Significance of biliary dysfunction in the pathogenesis of gallstone disease].
Il'chenko IA; Deliukina OV
Eksp Klin Gastroenterol; 2011; (7):70-8. PubMed ID: 22364003
[TBL] [Abstract][Full Text] [Related]
32. New therapeutic approach to overcome biliary sludge after liver transplantation.
Müller GE; Bockhorn H; Fleischmann R; Müller GH
Transplant Proc; 1981 Mar; 13(1 Pt 2):845-7. PubMed ID: 7022950
[No Abstract] [Full Text] [Related]
33. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.
Xu C
Hepatol Int; 2016 Mar; 10(2):286-93. PubMed ID: 26671825
[TBL] [Abstract][Full Text] [Related]
34. [Molecular mechanisms of bile formation and cholestatic diseases].
Poupon R
Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
[TBL] [Abstract][Full Text] [Related]
35. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
36. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
Sentilhes L; Verspyck E; Pia P; Marpeau L
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):458-60. PubMed ID: 16449148
[TBL] [Abstract][Full Text] [Related]
37. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
[No Abstract] [Full Text] [Related]
38. Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016?
Beaton MD; Al-Judaibi B
Saudi J Gastroenterol; 2016; 22(3):169-70. PubMed ID: 27184632
[No Abstract] [Full Text] [Related]
39. [Cholestatic liver disease in children].
Jankowska I; Pawłowska J; Swiatkowska E; Rujner J; Socha J
Przegl Epidemiol; 2002; 56 Suppl 5():16-21. PubMed ID: 15553067
[TBL] [Abstract][Full Text] [Related]
40. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
Mörk H; al-Taie O; Klinge O; Scheurlen M
Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
